According to the latest research report released by CITIC Securities, China's pharmaceutical sales channels are experiencing a notable transformation, shifting from in-hospital to out-of-hospital settings and from offline to online platforms. This transition is being propelled by several key factors: the imperative to control healthcare costs, adjustments in the distribution channels for original drugs, and the widespread integration of AI search and recommendation technologies. Consequently, the online sales rate of healthcare products is projected to witness a significant upsurge.

Leading pharmaceutical e-commerce platforms are poised to capitalize on this trend. By leveraging their strengths in traffic generation and cost-effective fulfillment, coupled with their robust capabilities in AI technology research, development, and productization, these platforms are set to seize emerging opportunities in AI-driven search and recommendation services, as well as health management solutions. This strategic move will enable them to further solidify and expand their market presence.